The Federal Trade Commission (FTC) is continuing to pursue pharmaceutical manufacturers for allegedly improperly listing ...

The FTC issued renewed warning letters to drugmakers that did not delist previously challenged Orange Book listings, ...

As explained more fully below, the Orange Book lists all drugs that the FDA has deemed to be safe and effective; for each drug, it also lists all patents that the manufacturer (the branded firm ...

The Federal Circuit recently considered the scope of a permanent injunction that prohibited a drug manufacturer from ...

Teva got more time to ask the Supreme Court to review a ruling that could strip hundreds of drug patents from a key FDA registry, a decision the company says could reshape how makers of brand-name ...

To advance policies that secure the future of a leading U.S. innovative industry, it is important in this instance to gain a deeper understanding of what generic drugs are, what the FTC is challenging ...